Vaccine Order Boosts Bavarian Nordic After Cancer Drug Flop

Biotech group Bavarian Nordic said it expected to win more contracts in the United States for its smallpox vaccine after securing an order from the U.S. government stockpile.
Reuters Health Information

This post was syndicated from Medscape Medical News Headlines. Click here to read the full text on the original website.

Be the first to comment

Leave a Reply